Hepatitis C in Drug and Alcohol Settings
People who inject drugs represent approximately 90% of newly acquired hepatitis C (HCV) infections. This workshop aims to provide addiction physicians, general practitioners, nurse practitioners, and other practitioners working in Drug and Alcohol settings with the skills and knowledge to diagnose HCV, manage comorbidities and treat HCV.
This course will be delivered in three parts
Part 1 consists of a 1.5-hour eLearning component introducing the learner to assessment, management and treatment of hepatitis C in drug and alcohol settings.
Part 2 consists of this 3-hour interactive training session building on the knowledge and skills gained in Part 1 through practical case discussions.
Part 3 consists of a post-workshop tailored capacity strengthening toolkit including: a checklist for the assessment and treatment of HCV in drug and alcohol settings; local referral pathways; Fibroscan® access forms; assessment pro forma; and quick reference guides.